A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension

Clinical trial NCT02230683 · COMPLETED

Trial details

NCT number: NCT02230683
Sponsor: Conatus Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Cirrhosis Hepatic Cirrhosis Portal Hypertension

Start date: 2014-08-01
Primary completion: 2015-05-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.